Druker Brian 4
4 · Vincera Pharma, Inc. · Filed Dec 28, 2020
Insider Transaction Report
Form 4
Druker Brian
Director
Transactions
- Award
Common Stock
2020-12-23+54,806→ 54,806 total - Award
Stock Option (right to buy)
2020-12-23+6,667→ 6,667 totalExercise: $19.00Exp: 2030-12-23→ Common Stock (6,667 underlying)
Footnotes (2)
- [F1]Received pursuant to the Merger Agreement, dated as of September 25, 2020, by and among LifeSci Acquisition Corp. ("LifeSci"), Vincera Pharma, Inc. ("Legacy Vincera") and LifeSci Acquisition Merger Sub, Inc., a wholly-owned subsidiary of LifeSci ("Merger Sub"), pursuant to which Merger Sub merged with and into Legacy Vincera, with Legacy Vincera surviving the merger as a wholly-owned subsidiary of LifeSci (which subsequently changed its name to "Vincera Pharma, Inc.").
- [F2]The option vests in full on the earlier of December 23, 2021, the next annual meeting of stockholders or the consummation of a change of control, subject to the director's continued service.